Anika Therapeutics Balance Sheet (2010-2026) | ANIK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	97.18M	90.98M	94.39M	90.33M	91.39M	87.78M	86.33M	79.74M	65.07M	70.65M	68.74M	68.63M	62.82M	62.37M	55.63M	53.37M	53.17M	57.99M	57.48M	41.02M
Short-term Investments (Quarter)			29.84M	29.31M	32.17M	34.17M	34.63M	30.63M	36.74M	34.68M	26.36M	32.08M	33.77M	28.36M	23.59M	21.99M	23.95M	22.19M	23.69M	25.77M
Cash & Current Investments (Quarter)	97.18M	90.98M	124.23M	119.64M	123.56M	121.94M	120.95M	110.37M	101.81M	105.33M	95.10M	100.71M	96.59M	90.72M	79.22M	75.36M	77.12M	80.18M	81.17M	66.79M
Receivables - Net (Quarter)	29.43M	32.35M	29.84M				34.63M	32.17M	38.36M	36.26M	26.36M	33.73M	33.77M	28.36M	23.59M	21.99M	24.75M	23.06M	23.69M	26.86M
Receivables (Quarter)	29.43M	32.35M	29.84M				34.63M	32.17M	38.36M	36.26M	26.36M	33.73M	33.77M	28.36M	23.59M	21.99M	24.75M	23.06M	23.69M	26.86M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	42.86M	35.02M	36.01M	35.23M	35.34M	37.24M	39.77M	41.32M	42.60M	43.72M	24.43M	49.41M	51.46M	39.63M	23.81M	21.34M	16.92M	16.28M	18.79M	22.84M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	8.30M	7.43M	8.29M	10.46M	8.96M	8.58M	8.83M	8.65M	7.79M	7.72M	7.48M	8.85M	6.94M	5.75M	5.49M	5.82M	5.27M	5.13M	3.40M	3.94M
Current Assets (Quarter)	177.76M	165.78M	168.53M	165.32M	167.86M	167.76M	169.55M	160.33M	152.20M	156.78M	163.31M	158.96M	155.00M	136.11M	113.65M	102.51M	99.32M	101.59M	103.36M	93.56M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	49.54M	49.11M	47.60M	47.95M	48.09M	47.39M	48.28M	48.80M	47.99M	45.94M	37.45M	46.06M	47.69M	44.57M	38.99M	40.46M	40.68M	40.68M	40.32M	39.72M
Goodwill (Quarter)	8.15M	7.95M	7.78M	7.62M	7.17M	6.72M	7.34M	7.46M	7.47M	7.25M	7.57M	7.40M	7.35M	7.66M	7.12M	7.42M	8.06M	8.05M	8.05M	7.89M
Intangibles (Quarter)	112.74M	112.74M	82.38M	80.44M	78.49M	76.55M	112.14M	72.65M	70.71M	112.14M	2.58M	49.95M	49.95M	0.60M	19.84M	1.70M	15.74M	1.65M	1.65M	1.70M
Goodwill & Intangibles (Quarter)	120.89M	120.69M	90.16M	88.06M	85.66M	83.27M	119.47M	80.11M	78.17M	119.39M	10.15M	57.35M	57.30M	8.26M	26.96M	9.12M	23.79M	9.70M	9.70M	9.59M
Long-Term Deferred Tax (Quarter)							1.45M	1.52M	1.50M	1.42M	1.49M	1.27M	1.36M	1.47M	1.18M	1.19M	1.25M	1.25M	1.27M	1.15M
Other Non-Current Assets (Quarter)	18.75M	23.67M	20.29M	20.39M	20.91M	18.34M	17.22M	18.13M	19.39M	18.95M	36.30M	17.57M	19.52M	11.31M	5.66M			5.51M	4.03M	4.30M
Non-Current Assets (Quarter)	185.37M	187.15M	179.01M	176.92M	186.27M	179.99M	179.58M	178.74M	176.68M	171.38M	107.32M	104.78M	107.66M	95.30M	89.09M	88.10M	88.36M	87.85M	86.91M	85.83M
Assets (Quarter)	363.13M	352.93M	347.54M	342.24M	354.12M	347.75M	349.13M	339.07M	328.88M	328.16M	270.63M	263.74M	262.65M	231.41M	202.74M	190.60M	187.68M	189.44M	190.27M	179.39M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	8.10M	7.94M	7.63M	7.44M	8.16M	8.35M	9.07M	8.95M	7.94M	8.25M	6.19M	10.02M	9.99M	6.80M	5.62M	5.28M	4.77M	4.73M	6.04M	6.34M
Payables (Quarter)	8.10M	7.94M	7.63M	7.44M	8.16M	8.35M	9.07M	8.95M	7.94M	8.25M	6.19M	10.02M	9.99M	6.80M	5.62M	5.28M	4.77M	4.73M	6.04M	6.34M
Accumulated Expenses (Quarter)	7.75M	17.34M	9.52M	7.46M	8.82M	11.17M	11.30M	19.75M	8.69M	10.97M	14.07M	8.60M	8.49M	18.69M	13.57M	5.95M	5.96M	14.36M	15.87M	14.63M
Other Accumulated Expenses (Quarter)	16.40M	17.34M	1.06M	1.15M	1.03M	0.50M	0.51M	0.57M	0.54M	0.51M	0.34M	0.48M	0.52M	0.38M	0.77M	0.78M	0.64M	0.75M	0.47M	0.48M
Short term Debt (Quarter)	16.87M	4.30M	4.32M	4.30M	4.32M
Current Leases (Quarter)			1.53M	0.12M	1.74M	1.92M	2.07M	2.10M	2.08M	2.05M	1.83M	2.13M	2.29M	2.29M	1.92M	1.87M	1.81M	1.73M	2.05M	1.94M
Current Taxes (Quarter)							0.81M	0.89M	0.93M	0.82M	1.24M	1.49M	0.08M	0.08M	0.06M	0.07M
Current Deferred Revenue (Quarter)																				0.23M
Total Current Liabilities (Quarter)	41.37M	28.77M	29.80M	26.99M	29.43M	26.35M	27.91M	28.69M	23.46M	28.06M	31.06M	28.46M	26.12M	25.49M	23.31M	17.90M	16.08M	19.09M	21.91M	20.97M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Liabilities from Discontinued Operations (Quarter)											0.99M				0.66M
Non-Current Deferred Tax Liability (Quarter)	13.10M	12.97M	10.16M	9.96M	8.22M	6.80M	6.44M	4.11M	3.23M	1.96M
Operating Leases (Quarter)	20.08M	19.64M	19.24M	18.82M	29.73M	29.18M	28.82M	28.28M	27.77M	27.25M	25.91M	26.34M	25.79M	25.24M	24.01M	23.56M	23.17M	22.78M	24.20M	23.79M
Other Non-Current Liabilities (Quarter)	16.90M		1.26M	0.68M	0.59M	0.47M	0.40M	0.40M	0.40M	0.40M	0.40M	0.40M	0.41M	0.81M	0.77M	0.74M	0.76M	0.76M	0.70M	0.73M
Total Non-Current Liabilities (Quarter)	59.43M	62.87M	59.19M	55.77M	67.38M	62.34M	63.17M	61.09M	54.47M	57.27M	57.96M	54.80M	51.91M	50.73M	47.98M	41.46M	39.25M	41.87M	46.10M	44.76M
Total Liabilities (Quarter)	76.33M	62.87M	60.45M	56.45M	67.97M	62.81M	63.56M	61.49M	54.87M	57.67M	58.37M	55.21M	52.32M	51.54M	48.75M	42.21M	40.01M	42.63M	46.80M	45.49M
Shareholder's Equity
Total Debt (Quarter)	16.87M	4.30M	4.32M	4.30M	4.32M
Common Equity (Quarter)	286.80M	290.06M	287.08M	285.79M	286.15M	284.94M	285.56M	277.59M	274.01M	270.49M	212.26M	208.54M	210.34M	179.86M	153.99M	148.40M	147.67M	146.81M	143.47M	133.90M
Shareholder's Equity (Quarter)	286.80M	290.06M	287.08M	285.79M	286.15M	284.94M	285.56M	277.59M	274.01M	270.49M	212.26M	208.54M	210.34M	179.86M	153.99M	148.40M	147.67M	146.81M	143.47M	133.90M
Liabilities and Shareholders Equity (Quarter)	363.13M	352.93M	347.54M	342.24M	354.12M	347.75M	349.13M	339.07M	328.88M	328.16M	270.63M	263.74M	262.65M	231.41M	202.74M	190.60M	187.68M	189.44M	190.27M	179.39M
Retained Earnings (Quarter)	-4.85M	-5.32M	-5.72M	222.65M	219.80M	215.63M	210.72M	200.37M	-6.16M	-6.56M	128.05M	-6.32M	-6.42M	93.53M	71.67M	66.79M	-4.75M	-4.94M	60.79M	55.73M
Treasury Shares (Quarter)		0.40M	0.16M	0.71M	0.72M	0.69M	0.68M	0.85M	0.16M	0.03M	0.19M	0.90M	0.88M	0.15M	0.84M	0.24M	0.96M		0.95M	0.23M

Research Tools

Anika Therapeutics Balance Sheet (2010-2026) | ANIK

Create an account

Sign In

Reset Password